Nuveen, LLC Arvinas, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 166,597 shares of ARVN stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166,597Holding current value
$1.27 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARVN
# of Institutions
229Shares Held
71.9MCall Options Held
1.52MPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA8.36MShares$63.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$51.3 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$47.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$31.3 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$25.4 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $406M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...